Key Highlights

Risk & Performance

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

N/A

6(100.0%)

6Total

N/A(6)

Loading network data...

Showing 6 of 6 trials

A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease

Role: collaborator

Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing

Role: collaborator

Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c

Role: collaborator

Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c

Role: collaborator

Clinical Evaluation of a Low Protein Content Formula in the First Months of Life: a RCT

Role: collaborator

Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants

Role: lead

All 6 trials loaded